Pharmaceutical Technology Europe, Aug 1, 2011 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology Europe, Aug 1, 2011
Editor's Comment
Gene-ius
By Rich Whitworth
There have been several new stories and reports lately that paint a rather gloomy picture of the state of pharma R&D.
Special Feature
The Challenges Of The Emerging Markets
By Bikash Chatterjee
The challenge with any of the emerging markets is in adjusting to the western regulatory concepts of quality and compliance.
The Many Varieties Of 'Emerging'
By Cole Shelton
While most companies recognise the significance of emerging markets, they struggle to jump the first hurdle in addressing these opportunities: defining the right product.
Making A Mark In Emerging Markets
By Marc Prieur
Marc Prieur of Aptar pharma describes success stories in emerging markets.
Information Technology
Managing Information Overload
By Adam Sherlock
Companies know they need regulatory information management, but they don't always know where to start and how to weave this capability across diverse technology applications.
Manufacturing
The Importance Of Filter Testing
By Graham Rideal
Graham Rideal of Whitehouse Scientific explains the importance of filter testing and offers some considerations with regards to choosing filter test methods.
Peer-Reviewed Research
Controlled Crystallization During Freeze-Drying
By Hans de Waard , Niels Grasmeijer , Wouter L.J. Hinrichs , Thomas De Beer , Henderik W. Frijlink
The authors discuss the preparation of lipophilic drug nanocrystals by controlled crystallization during freeze-drying.
Understanding Fluidized-Bed Granulation
By A. Burggraeve , T. Van Den Kerkhof , M. Hellings , J.P. Remon , C. Vervaet , T. De Beer
This study demonstrates the beneficial use of a spatial-filter velocimetry particle-size analyzer during granulation.
Controlled Release from Porous Platforms
By Spomenka Simovic , Dusan Losic , Krasimir Vasilev
The authors present a method for controlling the release of therapeutics by applying a plasma polymer layer to the surface of porous materials.
Industry Insider
Croatia, Pharma and Corruption
By Nathan Jessop
Croatia is on track to join the EU in 2013 and offers a well-developed pharmaceutical market. However, its EU membership application has undergone much scrutiny.
Ingredients
Improving API Synthesis
By Patricia Van Arnum
O-arylation and O-alkylation, a one-pot protein synthesis, a combined approach in continued and chemocatalysis, and green-chemistry applications are the target of some recent advances in API synthesis.
Agent-In-Place
Movin' On Out
By Control, a senior compliance officer
Visiting a new site or going down memory lane may not get you where you want to go.
News
News
By Stephanie Sutton
Is pharma failing in R&D?

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here